KBMED Secures DGDA Certification to Bangladesh Market

June 2025 – California, USA / Dhaka, Bangladesh — KBMED, a global leader in high-performance medical technology, proudly announces that four of its flagship products have officially received five-year medical device registration approval from the Directorate General of Drug Administration (DGDA) of Bangladesh. This marks a significant milestone in KBMED’s international expansion and strategic entry into the rapidly growing South Asian healthcare market.

The approved devices include: 💉

✅Spinal Anesthesia Needle

✅IV Cannula (IV Catheter)

✅Silicon Feeding Tube (Silicon Stomach Tube)

✅Enfit Enteral Syringe

This certification underscores KBMED’s commitment to compliance, quality, and innovation. Each of these products has undergone rigorous DGDA review, backed by comprehensive technical documentation, clinical validation, and adherence to international ISO and FDA standards. 🏅

Deepening Roots in Bangladesh: Supporting Healthcare Transformation

As one of the fastest-growing medical markets in South Asia, Bangladesh is investing heavily in modernizing its healthcare infrastructure. With this registration, KBMED is poised to contribute to this transformation by delivering international-standard products and services.

"This DGDA registration is not just regulatory clearance—it reflects our dedication to improving clinical care in Bangladesh," said Susan.S., the CEO of KBMED. “Over the next five years, we plan to build strong local partnerships, provide on-the-ground technical training, and support hospitals and healthcare providers with customized solutions.”

Expanding Global Reach with a Local Focus

Headquartered in California, KBMED operates in over 50 countries worldwide. The company is known for its mission: “Precision Medicine, Safeguarding Life”—and its continued expansion into Bangladesh aligns with its goal of making safe, reliable, and cost-effective medical devices accessible to all. With this initial portfolio of registered products, KBMED is set to introduce more innovative devices to the Bangladeshi market in the coming years, further strengthening its position as a trusted international medical brand.📌